$241 Million is the total value of Tavio Capital LLC's 15 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 40.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HCA | New | HCA HEALTHCARE INC | $27,377,000 | – | 219,983 | +100.0% | 11.37% | – |
WCG | New | WELLCARE HEALTH PLANS INC | $26,994,000 | – | 114,337 | +100.0% | 11.21% | – |
ZBH | Buy | ZIMMER BIOMET HLDGS INC | $26,875,000 | -14.4% | 259,115 | +8.6% | 11.16% | -8.8% |
MOH | Buy | MOLINA HEALTHCARE INC | $25,605,000 | +13.8% | 220,319 | +45.6% | 10.64% | +21.1% |
UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $23,131,000 | +318.1% | 198,447 | +358.5% | 9.61% | +345.2% |
LH | Buy | LABORATORY CORP AMER HLDGS | $16,045,000 | +215.2% | 126,977 | +333.2% | 6.66% | +235.5% |
MEDP | Buy | MEDPACE HLDGS INC | $6,716,000 | +29.4% | 126,887 | +46.4% | 2.79% | +37.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
ANTHEM INC | 10 | Q2 2019 | 22.5% |
BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
RETROPHIN INC | 9 | Q1 2019 | 3.4% |
ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
HUMANA INC | 8 | Q4 2019 | 37.8% |
UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-10-01 |
13F-HR | 2020-08-13 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-13 |
13F-HR | 2019-11-13 |
13F-HR | 2019-08-13 |
13F-HR | 2019-05-14 |
13F-HR | 2019-02-14 |
13F-HR | 2018-11-13 |
13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.